Skip to evidence report

IPSC.mesodermal_primed: Studies — page 7

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,329 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 6,001–7,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for IPSC.mesodermal_primed
#Trait / studyIndividual trait IDMean IC score
6001Fracture of lower limb | injuries & poisoningsUKBB000002550.88
6002Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T401ECGA0004010.88
6003PDLIM5 levelsGCST904701970.88
6004Diacylglycerol (18:0_18:1) levelsGCST900247140.88
6005Deviated nasal septumFING000004090.88
6006NRCAM levelsGCST904700820.87
6007Principal component-derived dietary pattern 16GCST901330210.87
6008Bicarbonate (minimum, inv-norm transformed)GCST904751500.87
6009Concentration of HDL particlesGCST904974140.87
6010Triglycerides to Total Lipids in Medium HDL percentageGCST904986820.87
6011Type 1 diabetesGCST900187050.87
6012Depression | Mental distressUKBB000001650.87
6013wg rh intensity-contrast paracentralGCST900038430.87
6014SCGN levelsGCST904705440.87
6015Monounsaturated fatty acids to total fatty acids percentageGCST904991090.87
6016Prescriptions - sulfonylurea|diabetesUKBB000007030.87
6017Reticulocyte countGCST0046220.87
6018EPHA4 levelsGCST904691310.87
6019Other mental disorder | mental disordersUKBB000006140.87
6020LTB4R levelsGCST904221640.87
6021Heart attackGCST904681320.87
6022LTA levelsGCST904698130.87
6023ICD10 D25: Leiomyoma of uterusGCST904542040.86
6024DBI/EDAR ratioGCST903144080.86
6025ITGB1 levelsGCST904696430.86
6026T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122)GCST903209410.86
6027Triglycerides to Total Lipids in Medium VLDL percentageGCST904990730.86
6028ALCAM/NOTCH1 ratioGCST903132410.86
6029Iron deficiency anaemiaFING000006990.86
6030Volume of left whole amygdalaGCST904749860.86
6031FABP2/LGALS4 ratioGCST903147560.86
6032Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448)GCST901329670.86
6033EFNA4 levelsGCST904690810.86
6034IDP dMRI TBSS L3 Uncinate fasciculus RGCST900042150.86
6035Histidine levelsGCST900928300.86
6036rfMRI connectivity (ICA25 edge 101)GCST900047440.86
6037Skin red/green componentGCST903202580.85
6038RHOC/TBCC ratioGCST903157750.85
6039Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422ECGU0004220.85
6040aseg rh volume Lateral-VentricleGCST900026330.85
6041GLA levelsGCST904693540.85
6042HYOU1/PTPRF ratioGCST903151020.85
6043MSRA/P4HB ratioGCST903154950.85
6044Phospholipids in IDLGCST904976260.85
6045rfMRI connectivity (ICA100 edge 614)GCST900054670.85
6046PMVK levelsGCST904702720.85
6047Free cholesterol to total lipids ratio in small HDLGCST900929490.85
6048EBAG9/MITD1 ratioGCST903145660.85
6049Alzheimer's disease or family history of Alzheimer's diseaseGCST900128770.85
6050Physical activity (Relative amplitude)GCST900614320.84
6051Saturated fatty acids levelsGCST905026700.84
6052PTPRH levelsGCST904703820.84
6053Prescriptions - thiazide diuretic|diureticUKBB000007040.84
6054BLVRB/CA1 ratioGCST903135210.84
6055aseg rh volume HippocampusGCST900026410.84
6056LTA4H levelsGCST904698120.84
6057Cholesteryl esters to total lipids in small VLDL percentage (UKB data field 23601)GCST902696980.84
6058Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T377ECGU0003770.84
6059Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T500ECGA0005000.84
6060Deaf mutism, not elsewhere classifiedFING000003780.84
6061Emotional neglectGCST905518460.84
6062Cholesteryl esters to total lipids ratio in small LDLGCST900929590.84
6063Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T482ECGU0004820.84
6064Hypertrophy of breast in women and menFING000006450.84
6065CGREF1/FAM3C ratioGCST903140320.83
6066KLKB1 levelsGCST904697080.83
6067TANK levelsGCST904708030.83
6068DSG3/FABP9 ratioGCST903145590.83
6069Spleen iron concentrationGCST901018310.83
6070LAT/PLXNA4 ratioGCST903152860.83
6071Free cholesterol levels in very small VLDLGCST900930320.83
6072Gestational diabetes (for exclusion)FING000005730.83
6073N-delta-acetylornithine levelsGCST902006910.83
6074CLIP2/LAT2 ratioGCST903141280.83
6075FST/FSTL3 ratioGCST903148820.83
6076Stenosis and insufficiency of lacrimal passagesFING000013340.83
6077SMPD1 levelsGCST904706840.83
6078SERPINI2 levelsGCST904706030.83
6079Degree of unsaturationGCST905027530.83
6080Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12ECGA0000120.83
6081Total lipids in very small VLDLGCST905008130.83
6082AXIN1/IKBKG ratioGCST903134090.83
6083Phospholipids in IDL (UKB data field 23525)GCST902696220.83
6084Cholesterol levels in large VLDLGCST900928680.82
6085Phospholipids in large HDLGCST904978470.82
6086aparc-a2009s rh area G-postcentralGCST900033980.82
6087Concentration of very small VLDL particlesGCST905008260.82
6088Basophil percentage of white cellsGCST0046310.82
6089IL1R1 levelsGCST904695710.82
6090GDI2 levelsGCST900880040.82
6091Systolic blood pressureGCST904727800.82
6092DNAJA2/HPCAL1 ratioGCST903145030.82
6093Nontoxic nodular goiter | endocrine/metabolicUKBB000005290.82
6094LAMA4/NID1 ratioGCST903152720.82
6095X-11787 levelsGCST902004650.82
6096DTI TBSS MD Posterior corona radiata RGCST903845980.82
6097Thick vs thin eyebrowsGCST0060930.82
6098BLVRB/CA2 ratioGCST903135220.82
6099Creatinine levelsGCST901327190.82
6100Cholesterol to total lipids ratio in large HDLGCST900928450.82
6101Own or rent accommodation lived in - Own outright (by you or someone in your household) | HouseholdUKBB000006230.81
6102AXIN1/ITGB1BP2 ratioGCST903134120.81
6103Phospholipids to total lipids in medium HDL percentage (UKB data field 23639)GCST902697360.81
6104Polyunsaturated fatty acid levelsGCST905021340.81
6105Free cholesterol in medium LDLGCST904987740.81
6106Activities undertaken to treat depression | DepressionUKBB000000100.81
6107RAD23B levelsGCST904704180.81
6108Gonarthrosis [arthrosis of knee] | ArthrosisUKBB000002900.81
6109PIKFYVE levelsGCST904702350.81
6110F-fatty/salty food liking (derived food-liking factor)GCST900947590.81
6111IRAK1 levelsGCST904696270.81
6112Average diameter for HDL particlesGCST901327020.81
6113Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)GCST901329310.81
6114Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST900929430.81
6115Total lipids in medium VLDL (UKB data field 23503)GCST902696000.81
6116Total cholesterol minus HDL-C levelsGCST900929300.80
6117Bifidobacterium catenulatum abundance in stoolGCST900322240.80
6118DCXR/GSTA1 ratioGCST903144370.80
6119CKAP4/LTBR ratioGCST903140740.80
6120Basophil countGCST900187260.80
6121FABP9 levelsGCST904691790.80
6122EPHA2 levelsGCST904691300.80
6123Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14ECGA0000140.80
6124Left-hemisphere control network to hippocampus white-matter structural connectivityGCST903027560.80
6125Female infertilityFING000005360.80
6126CD58/ERBB3 ratioGCST903138480.80
6127Thyroid stimulating hormone levelsGCST902963330.80
6128PSG1 levelsGCST904703530.80
6129Left-hemisphere default mode network to thalamus white-matter structural connectivityGCST903027670.80
6130SOST/SPP1 ratioGCST903158710.80
6131T1 FIRST volume L HippGCST903839900.80
6132ERBIN/SIRT2 ratioGCST903146960.79
6133IDP dMRI ProbtrackX ISOVF slf rGCST900045470.79
6134Basophil percentage of white cells varianceGCST905656880.79
6135CRTAM/PDCD1 ratioGCST903142790.79
6136OSCAR levelsGCST904701310.79
6137BCAN/DPP6 ratioGCST903134780.79
6138Cholesteryl esters in large VLDL (UKB data field 23499)GCST902695960.79
6139CA2/CA3 ratioGCST903135760.79
6140LACRT levelsGCST904697250.79
6141CASP8/SEPTIN9 ratioGCST903136580.79
6142EIF4G1/MAVS ratioGCST903146360.79
6143Cholesteryl ester levels in medium LDLGCST900929060.79
6144Heart valve replaced (PheCode 395.6)GCST904759150.79
6145FOLR2/HAVCR2 ratioGCST903148650.79
6146Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST905009490.79
6147Age-related macular degenerationGCST900861110.79
6148aparc-pial rh area parsopercularisGCST900031910.79
6149PDGFRB levelsGCST904701920.79
6150DUSP3 levelsGCST904690530.79
6151DAPP1/PTPN6 ratioGCST903143970.79
6152Polycystic ovarian syndrome, consortium definitionFING000011840.79
6153HAVCR1 levelsGCST904694310.78
6154CDC37 levelsGCST904686650.78
6155Chronic Kidney Disease, Stage IV (PheCode 585.34)GCST904761300.78
6156Linoleic acid to total fatty acids percentageGCST905020250.78
6157Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDLGCST900930430.78
6158SLC51B levelsGCST904706640.78
6159MANF/TXNDC5 ratioGCST903153700.78
6160Phospholipid levels in small HDLGCST900929520.78
6161AKR1B1 levelsGCST904682730.78
6162Concentration of small HDL particlesGCST904994610.78
6163Free cholesterol in VLDL (UKB data field 23420)GCST902695170.78
6164Cholesteryl esters in very small VLDL (UKB data field 23520)GCST902696170.78
6165DTI TBSS L3 Anterior corona radiata LGCST903845470.78
6166Phospholipids to Total Lipids in Medium LDL percentageGCST904988520.77
6167BA-exvivo rh area BA1GCST900032210.77
6168DTI TBSS MD Superior corona radiata LGCST903845970.77
6169Principal component-derived dietary pattern 28GCST901330330.77
6170PTPN1 levelsGCST904703760.77
6171CLEC6A levelsGCST904687770.77
6172REN levelsGCST904704540.77
6173PMM2 levelsGCST904702700.77
6174IDP T1 FAST ROIs L pallidumGCST900025530.77
6175Osteopathies and chondropathiesFING000009130.77
6176HNRNPK/USP8 ratioGCST903150700.77
6177Treatment/medication code - atenolol | MedicationsUKBB000008420.77
6178REST UKBBICA NODEamps25 0005GCST903854880.77
6179LCN2/RETN ratioGCST903153080.77
6180AMOTL2 levelsGCST904682940.77
6181Concentration of large VLDL particlesGCST904982260.77
6182Dermatophytosis (PheCode 110.1)GCST904755610.77
6183Reason for reducing amount of alcohol drunk - Health precaution | AlcoholUKBB000007340.77
6184MESD/NCK2 ratioGCST903154210.77
6185Phosphatidylcholine (14:0_22:6) levelsGCST900242340.77
6186FAM3B/GPA33 ratioGCST903147780.77
6187Ceramide_40:1_[M-H]1- levelsGCST900601980.76
6188Linoleic acid levelsGCST905020100.76
6189SPOCK2 levelsGCST902429870.76
6190COMP/MYOC ratioGCST903141910.76
6191aparc-a2009s rh area G-pariet-inf-AngularGCST900033950.76
6192OPTC levelsGCST904701280.76
6193Triglycerides in HDLGCST904974670.76
6194COL18A1/RARRES2 ratioGCST903141690.76
6195AZU1/MPO ratioGCST903134250.76
6196DTI TBSS L3 Superior corona radiata LGCST903845490.76
6197DTI TBSS L3 Fornix cres+Stria terminalis LGCST903845630.76
6198Total lipids in large VLDLGCST904982070.76
6199GBP6 levelsGCST902413680.76
6200Female infertility, associated with anovulationFING000005370.76
6201IDP dMRI ProbtrackX ICVF cgh rGCST900043820.76
6202LAT/LYN ratioGCST903152830.76
6203SPINT1/SUSD2 ratioGCST903158780.76
6204ADH4/KYNU ratioGCST903131930.75
6205Number of operations, self-reported | OperationsUKBB000005390.75
6206RHOC levelsGCST904704670.75
6207FLT4/KDR ratioGCST903148610.75
6208aparc-pial rh area superiorparietalGCST900032020.75
6209Other and unspecified iron deficiencyFING000009400.75
6210Free testosterone levelsGCST902398260.75
6211T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119)GCST903206820.75
6212Total phospholipids in lipoprotein particles (UKB data field 23411)GCST902695080.75
6213IGSF9 levelsGCST904695410.75
6214IDP dMRI TBSS FA Retrolenticular part of internal capsule LGCST900038980.75
6215Volume of left accessory basal nucleusGCST904749400.75
6216IDP T1 FAST ROIs R putamenGCST900025520.75
6217BIRC2 levelsGCST904684460.75
6218Lipoma of skin and subcutaneous tissue (PheCode 214.1)GCST904756190.75
6219Spread type: Any oil based spread vs never use spread (UKB data field 1428)GCST901329490.75
6220REST UKBBICA NODEamps25 0007GCST903854900.75
6221Total lipid levels in large LDLGCST900928620.75
6222Coronary artery disease (confirmatory factor analysis Factor 16)GCST903093500.75
6223Reason for reducing amount of alcohol drunk - Other reason | AlcoholUKBB000007350.75
6224Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T182ECGA0001820.74
6225Polyunsaturated fatty acids levels (UKB data field 23446)GCST902695430.74
6226ICAM5 levelsGCST904695020.74
6227TGFBR3 levelsGCST904708480.74
6228Triglycerides to total lipids ratio in very large HDLGCST900930150.74
6229SFTPA2/SFTPD ratioGCST903158390.74
6230Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580)GCST902696770.74
6231Blood cell traits latent factor 20 (red cell)GCST905592620.74
6232Spondylosis and allied disorders (PheCode 721)GCST904762350.74
6233VSIG4 levelsGCST904710520.74
6234ROBO2/SFTPD ratioGCST903157850.74
6235Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST904985500.74
6236DTI autoptx FA fmi tractGCST903851230.74
6237Cholesterol | Blood biochemistryUKBB000001340.74
6238MCAM/NTRK3 ratioGCST903154090.74
6239TNFSF11 levelsGCST904709180.74
6240Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9)GCST904759080.74
6241Hip fractureGCST901612400.74
6242APOC1 levelsGCST904683360.74
6243Cholesterol in medium HDL (UKB data field 23568)GCST902696650.74
6244Age when finished full-time education (weighted GWA)GCST902672810.74
6245CLEC1B/EGF ratioGCST903140890.73
6246DARS1/USP8 ratioGCST903144070.73
6247Anaphylactic shock due to adverse effect of correct drug or medication properly administeredFING000000840.73
6248Psoas tendinitisFING000012210.73
6249Cholesteryl ester levels in small LDLGCST900929580.73
6250Blood cell traits latent factor 13 (red cell)GCST905592550.73
6251Cholesterol in Large LDLGCST904979190.73
6252DBN1 levelsGCST904689500.73
6253ITIH4 levelsGCST904696510.73
6254aseg lh volume CerebralWhiteMatterGCST900026150.73
6255Total cholesterol levels (UKB data field 23400)GCST902694970.73
6256aparc-a2009s rh area G-occipital-supGCST900033900.73
6257SRPX levelsGCST904707440.73
6258MYL3 levelsGCST904699770.73
6259aparc-DKTatlas rh area precentralGCST900032870.73
6260Total cholesterol response to statins (relative logarithmic difference)GCST904556080.73
6261TARBP2/TDRKH ratioGCST903159020.73
6262Omega-3 fatty acid levelsGCST905020620.73
6263Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T227ECGU0002270.72
6264TNR levelsGCST904709290.72
6265AXL/IL18BP ratioGCST903134200.72
6266Mean corpuscular hemoglobinGCST900187440.72
6267Docosahexaenoic acid to total fatty acids percentageGCST905019910.72
6268Gamma-CEHC glucuronide levelsGCST901999410.72
6269KLK13 levelsGCST904696990.72
6270HippSubfield lh volume Whole-hippocampusGCST900026890.72
6271DLL1/EFEMP1 ratioGCST903144940.72
6272PLA2G1B levelsGCST904702460.72
6273Cholesteryl esters in medium HDL (UKB data field 23569)GCST902696660.72
6274Psoriasis vulgarisGCST900186870.72
6275Miserableness | Mental healthUKBB000004780.72
6276TNFAIP2 levelsGCST904708960.72
6277Free cholesterol levels in small VLDLGCST900929720.72
6278Disorders of orbitFING000004490.72
6279SH2B3/SUGT1 ratioGCST903158400.72
6280C-reactive protein | Blood biochemistryUKBB000001130.72
6281CDCP1/MSR1 ratioGCST903139380.72
6282CD5 levelsGCST904686410.72
6283Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressureUKBB000003760.72
6284Transient global amnesiaFING000013740.71
6285Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T421ECGU0004210.71
6286Cholesteryl ester levels in very large VLDLGCST900930180.71
6287Triglyceride levels in large LDLGCST900928660.71
6288Hypertrophy of breastFING000006440.71
6289GSR levelsGCST904694100.71
6290CD300C/HAVCR2 ratioGCST903137890.71
6291RARRES2/TFPI ratioGCST903157600.71
6292HEPH levelsGCST904694460.71
6293Treatment/medication code - aspirin | MedicationsUKBB000008410.71
6294ITM2A levelsGCST904696530.71
6295HYAL1 levelsGCST904694950.70
6296CD69/CDKN2D ratioGCST903138660.70
6297Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary AdministrationUKBB000004640.70
6298Total free cholesterol levels (UKB data field 23419)GCST902695160.70
6299IDP T1 FAST ROIs R caudateGCST900025500.70
6300WFDC12 levelsGCST904710730.70
6301Frailty (Factor 3 - Multimorbidity)GCST906240490.70
6302T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 32)GCST903205950.70
6303C5 levelsGCST904685000.70
6304EDAR/TNFSF12 ratioGCST903145910.70
6305BCAN/KLK6 ratioGCST903134790.70
6306FGF5 levelsGCST904692260.70
6307NADK/S100A11 ratioGCST903155130.70
6308ANGPT1/CPXM1 ratioGCST903132620.70
6309Inguinal herniaGCST900186480.69
6310CTHRC1 levelsGCST904689020.69
6311LDLRAP1 levelsGCST904697490.69
6312Occlusion and stenosis of precerebral arteries (PheCode 433.1)GCST904759860.69
6313Omega-3 fatty acid levelsGCST905024250.69
6314Normotensive glaucomaFING000008920.69
6315Ceramide (d18:2/24:1) levelsGCST900246840.69
6316Total esterified cholesterol levelsGCST905000360.69
6317Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13ECGA0000130.69
6318Cholesterol in Small HDLGCST904993480.69
6319ALOX15B levelsGCST906175470.69
6320SLC27A4 levelsGCST904706570.69
6321LDL direct | Blood biochemistryUKBB000003860.69
6322CDKN1A levelsGCST904686840.69
6323F-healthy food liking (derived food-liking factor)GCST900947790.69
6324Mean platelet volume at deliveryGCST903022320.69
6325EDAR/SNAP23 ratioGCST903145870.69
6326Presence of cardiac and vascular implants and grafts | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007080.69
6327aparc-DKTatlas rh area caudalmiddlefrontalGCST900032670.68
6328CD244/TREML2 ratioGCST903137670.68
6329Fruit intake (standard GWA)GCST902672820.68
6330Total esterified cholesterol levels (UKB data field 23415)GCST902695120.68
6331Systolic blood pressure, manual reading | Blood pressureUKBB000008100.68
6332wg lh intensity-contrast transversetemporalGCST900038250.68
6333Clonal haematopoiesis of indeterminate potential (DNMT3A mutation)GCST901652710.68
6334ATRAID levelsGCST904683990.68
6335T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST903208980.68
6336Cholesteryl esters to total lipids ratio in medium HDLGCST900928950.68
6337Chronic pancreatitisGCST900186010.68
6338Baked/steamed fish likingGCST900946960.68
6339DAG1/F2R ratioGCST903143740.68
6340Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4)GCST904762430.68
6341HSDL2 levelsGCST904694850.68
6342LYPD3 levelsGCST904698280.68
6343Total lipids in IDL (UKB data field 23524)GCST902696210.68
6344Body fat rateGCST902786190.68
6345SEPHS1 levelsGCST902427400.68
6346Alzheimer's disease or family history of Alzheimer's diseaseGCST0073200.68
6347MAP3K5 levelsGCST904698540.68
6348FHIT/GLOD4 ratioGCST903148170.68
6349Phosphoglycerides levels (UKB data field 23434)GCST902695310.68
6350SERPINH1 levelsGCST904706010.68
6351DAB2/FKBP1B ratioGCST903143620.68
6352CD276 levelsGCST904686140.67
6353RBKS levelsGCST904704330.67
6354Substance dependenceGCST900187040.67
6355IDP dMRI TBSS ISOVF Cingulum cingulate gyrus RGCST900045110.67
6356CPA1/CPB1 ratioGCST903142020.67
6357Waking up during the night and not easily going back to sleepGCST904763860.67
6358Modified Stumvoll Insulin Sensitivity IndexGCST902675740.67
6359Graves' disease (PheCode 242.1)GCST904756440.67
6360RBPMS2 levelsGCST904704410.67
6361Mid-point of the five least active hours of the dayGCST900614340.67
6362Plasma X-24544 levels in chronic kidney diseaseGCST902667570.67
6363Chained arithmetic | Fluid intelligence / reasoningUKBB000001260.67
6364PSMD9/UBAC1 ratioGCST903157350.67
6365P4HB levelsGCST904701400.67
6366Beta-hydroxyisovaleroylcarnitine levelsGCST901998020.67
6367Free cholesterol in large HDLGCST904977800.67
6368APOA1 levelsGCST902695370.67
6369Omega-6 fatty acid levelsGCST905020950.67
6370Concentration of very large HDL particlesGCST905004310.67
6371PDGFB/VEGFC ratioGCST903156350.67
6372Cholesterol to total lipids in small LDL percentage (UKB data field 23625)GCST902697220.67
6373Cholesterol to Total Lipids in Large VLDL percentageGCST904981300.67
6374IDUA levelsGCST904695080.66
6375Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivityGCST903026740.66
6376PCDH7 levelsGCST904701710.66
6377COCH levelsGCST904688100.66
6378Concentration of small LDL particlesGCST900929630.66
6379Total cholines levels (UKB data field 23436)GCST902695330.66
6380eGFR in diabetes mellitus (loose) (minimal adjustment)GCST906247830.66
6381aparc-Desikan lh thickness paracentralGCST900034610.66
6382ThalamNuclei lh volume L-SgGCST900027160.66
6383Left-hemisphere limbic network to thalamus white-matter structural connectivityGCST903027360.66
6384Prevotella sp000434975 abundance in stoolGCST900325180.66
6385ThalamNuclei lh volume PuIGCST900027140.66
6386CASP2 levelsGCST904685440.66
6387CLEC1B/HBEGF ratioGCST903140920.65
6388LSIL lesion of the cervix uteri, vagina or vulvaFING000007330.65
6389IDP T1 FAST ROIs R lingual gyrusGCST900025220.65
6390GALNT5 levelsGCST904692980.65
6391CBLN4/RET ratioGCST903136600.65
6392EFNA4/TNFRSF10B ratioGCST903146050.65
6393PPP1R12A levelsGCST904703000.65
6394B4GALT1/SPON2 ratioGCST903134340.65
6395HematocritGCST902786340.65
6396Umbilical herniaFING000013950.65
6397GAPDH levelsGCST904693020.65
6398Medication use (drugs used in diabetes)GCST900187610.65
6399GPC1 levelsGCST904693860.65
6400Malignant neoplasm of bladder (PheCode 189.21)GCST904755990.65
6401ATXN10/SLC27A4 ratioGCST903133990.65
6402aparc-Desikan lh volume parstriangularisGCST900027870.64
6403Cholesteryl esters to total lipids ratio in small VLDLGCST900929710.64
6404XPNPEP2 levelsGCST904710840.64
6405GoutFING000005870.64
6406CD3 on Terminally Differentiated CD4+ T cellGCST900018440.64
6407LBR/POLR2F ratioGCST903152970.64
6408ADAMTSL2 levelsGCST904682280.64
6409RGCC levelsGCST904704610.64
6410Cholesterol to total lipids ratio in small LDLGCST900929570.64
6411USP8 levelsGCST904710220.64
6412high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753500.64
6413DAB2 levelsGCST904689420.64
6414DTI TBSS L1 Posterior limb of internal capsule RGCST903844460.64
6415IDP T1 FAST ROIs R postcent gyrusGCST900024840.64
6416CELA3A/CPA1 ratioGCST903140090.64
6417PXN levelsGCST904703960.64
6418SMAD3 levelsGCST904706770.64
6419T1 CAT WM unnormalised volumeGCST903839830.64
6420Mean corpuscular hemoglobinGCST900023230.64
6421AFP levelsGCST902786150.64
6422Triacylglycerol (50:0) [NL-18:0] levelsGCST900251510.64
6423CTSE levelsGCST904689110.64
6424F-acquired taste liking (derived food-liking factor)GCST900947910.64
6425ICA1 levelsGCST904694970.64
6426F-coffee/alcohol liking (derived food-liking factor)GCST900947370.64
6427Remnant cholesterol (non-HDL, non-LDL -cholesterol) levels (UKB data field 23402)GCST902694990.63
6428Total lipid levels in LDLGCST900928860.63
6429LAG3/VCAM1 ratioGCST903152700.63
6430APOB levelsGCST900928090.63
6431CD300C/CLEC14A ratioGCST903137860.63
6432CD46/TIMP1 ratioGCST903138370.63
6433NUDC levelsGCST904701020.63
6434Lysophosphatidylcholine (24:0) [sn2] levelsGCST900241870.63
6435aparc-DKTatlas rh volume superiorparietalGCST900029200.63
6436HypertensionGCST904681350.63
6437CDKN1A/TMSB10 ratioGCST903139780.63
6438CASP3 levelsGCST904685450.63
6439Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005930.63
6440Urate levels (UKB data field 30880)GCST904681070.63
6441GDNF levelsGCST904693230.63
6442Number of non-cancer illnesses (standard GWA)GCST902672900.63
6443Other specified/unspecified inflammatory spondylopathiesFING000011090.62
6444Medication use (adrenergics, inhalants)GCST900187790.62
6445ICD10 N86: Erosion and ectropion of cervix uteriGCST904542170.62
6446Mean volume of bilateral amygdalaGCST904749920.62
6447Pneumoconiosis due to other inorganic dustsFING000011730.62
6448Treatment or medication use - amlodipine (UKB data field 20003_1140879802)GCST900421950.62
6449Neutrophil countGCST900023980.62
6450MRPL33 levelsGCST906179860.62
6451FABP4 levelsGCST904691760.62
6452Linoleic acid levelsGCST905022940.62
6453S100A11 levelsGCST904705120.62
6454T1 FreeSurfer DK rh MeanThickness thicknessGCST903857570.62
6455LRRN1 levelsGCST904698060.62
6456Alanine levelsGCST900928060.62
6457Degree of unsaturationGCST905001750.62
6458PDGF-BB levelsGCST904284300.62
6459Operation code - coronary artery bypass grafts (cabg) | OperationsUKBB000005560.62
6460Cholesterol in medium VLDL (UKB data field 23505)GCST902696020.62
6461HAVCR1 levelsGCST900120410.62
6462Lysophosphatidylcholine (26:0) [sn1] levelsGCST900241880.62
6463ADH4/RBP5 ratioGCST903131940.62
6464Body fat percentage (adjusted for testosterone and SHBG)GCST904321800.61
6465EDA2R levelsGCST904690670.61
6466Triglycerides to Total Lipids in Small HDL percentageGCST904995300.61
6467F-glutamate liking (derived food-liking factor)GCST900947720.61
6468Phospholipid levels in VLDLGCST900930010.61
6469HJV levelsGCST904694550.61
6470MVK levelsGCST904699670.61
6471Triglycerides to Total Lipids in Small VLDL percentageGCST904999340.61
6472Presence of other functional implants | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007090.61
6473Nontoxic multinodular goiter | endocrine/metabolicUKBB000005280.61
6474ROR1/THBD ratioGCST903157860.61
6475REST UKBBICA NODEamps25 0003GCST903854860.61
6476Total Lipids in VLDLGCST905002360.61
6477RILP levelsGCST904704710.61
6478IDP dMRI TBSS MO Anterior corona radiata RGCST900039740.61
6479Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T475ECGA0004750.61
6480DTI TBSS L3 Posterior corona radiata LGCST903845510.61
6481Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)FING000008660.61
6482CDKN1A/TACC3 ratioGCST903139750.61
6483Saturated fatty acids levelsGCST905026580.60
6484PGLYRP1 levelsGCST904702190.60
6485PKD1 levelsGCST904702400.60
6486Docosahexaenoic acid levelsGCST905019780.60
6487CSF2RB levelsGCST904688830.60
6488Degree of unsaturationGCST905022310.60
6489VEGFA levelsGCST904710340.60
6490ADIPOQ levelsGCST902930860.60
6491Takes medication for heart attack?GCST904752120.60
6492CFB levelsGCST902407780.60
6493Atrial septal defectFING000001280.60
6494Major dietary changes in the last 5 years - Yes, because of other reasons | DietUKBB000004230.60
6495Obesity (PheCode 278.1)GCST904757620.60
6496ADGRG2/ITGB1 ratioGCST903131850.60
6497Triglyceride to phosphoglyceride ratioGCST904999920.60
6498BAX levelsGCST904684240.60
6499Fracture of lower leg, including ankleFING000005550.60
6500Phosphatidylcholine acyl-alkyl C36:5 levelsGCST902400730.60
6501F-highly palatable foods liking (derived food-liking factor)GCST900947850.60
6502Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T219ECGU0002190.60
6503DTI TBSS L2 FornixGCST903844810.60
6504CLSTN2 levelsGCST904687890.60
6505IDP dMRI TBSS ISOVF Superior longitudinal fasciculus LGCST900045180.59
6506EBAG9/TBCC ratioGCST903145680.59
6507CDH17/PTPRM ratioGCST903139430.59
6508Male-pattern baldnessGCST0066610.59
6509ADGRG2/SDC1 ratioGCST903131870.59
6510DAPK2 levelsGCST902408770.59
6511CA1 levelsGCST904685100.59
6512Free cholesterol in medium VLDL (UKB data field 23507)GCST902696040.59
6513Primary gonarthrosis, bilateralFING000012130.59
6514TREML2 levelsGCST904709620.59
6515AMY1A or AMY1B or AMY1C levelsGCST904682970.59
6516CPE levelsGCST904688410.59
6517Blood cell traits latent factor 23 (white cell)GCST905592650.59
6518RILPL2 levelsGCST904704700.59
6519Immature fraction of reticulocytesGCST0046280.59
6520MAX/TDRKH ratioGCST903154060.59
6521Neurofibromatosis, type 2FING000008670.59
6522SLA2 levelsGCST904706480.58
6523estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed)GCST904752850.58
6524SERPINB1/TMSB10 ratioGCST903158300.58
6525Number of diet questionnaires completed | Diet questionnaire performanceUKBB000005360.58
6526CEP85/ZBTB16 ratioGCST903140260.58
6527Volume of right paralaminar nucleusGCST904750480.58
6528HSD17B14 levelsGCST904694830.58
6529Immature reticulocyte fraction (UKB data field 30280)GCST904680790.58
6530Parkinson's disease or first degree relation to individual with Parkinson's diseaseGCST0093250.58
6531Haematocrit percentage | Blood countUKBB000002920.58
6532CLC/RNASE3 ratioGCST903140770.58
6533BST2/CEACAM1 ratioGCST903135370.58
6534CES3 levelsGCST904687200.58
6535Tea difference likingGCST900948550.58
6536Cholesteryl ester levels in LDLGCST900928840.58
6537OsteoarthritisGCST904763830.58
6538Cholesteryl Esters in Medium LDLGCST904987380.58
6539Cholesterol to Total Lipids in Very Large HDL percentageGCST905003330.58
6540ENG levelsGCST904691080.58
6541aparc-a2009s rh area S-collat-transv-antGCST900034200.58
6542aseg global intensity WM-hypointensitiesGCST900037560.58
6543HematocritGCST900187400.58
6544Prostate cancerGCST900186850.57
6545DBNL/DNAJA2 ratioGCST903144150.57
6546Calculus of kidney and ureter | UrolithiasisUKBB000001160.57
6547DCN levelsGCST904689560.57
6548T1 CAT volume Vermis VIIIaGCST903841280.57
6549CCDC80 levelsGCST904685620.57
6550DDR1/SFTPD ratioGCST903144430.57
6551Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3)GCST900439460.57
6552CXCL16 levelsGCST900120590.57
6553Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | MedicationUKBB000004550.57
6554Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney diseaseGCST902659710.57
6555T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92)GCST903206550.57
6556COL24A1 levelsGCST904688140.57
6557F-low caloric food liking (derived food-liking factor)GCST900947950.57
6558Cholesteryl esters to total lipids in small HDL percentage (UKB data field 23646)GCST902697430.57
6559Free cholesterol in IDL (UKB data field 23528)GCST902696250.57
6560Docosahexaenoic acid to total fatty acids percentageGCST904972680.57
6561T1 CAT volume L TemporalOccipitalFusiformCortexGCST903840760.57
6562Concentration of LDL particlesGCST900928870.57
6563Phospholipids to Total Lipids in Large VLDL percentageGCST904982580.57
6564CALCOCO1/METAP2 ratioGCST903136060.57
6565aparc-DKTatlas rh area superiorparietalGCST900032920.57
6566DNAJB1/STIP1 ratioGCST903145130.57
6567Other disorders of circulatory system | circulatory systemUKBB000006070.56
6568CXCL6 levelsGCST904689330.56
6569Massiliomicrobiota abundance in stoolGCST900324700.56
6570CXCL5/PPIB ratioGCST903143520.56
6571Phospholipids in medium HDL (UKB data field 23567)GCST902696640.56
6572Cholesteryl ester levels in large LDLGCST900928580.56
6573Free Cholesterol to Total Lipids in Small VLDL percentageGCST904998320.56
6574Other hypertrophic and atrophic conditions (PheCode 701)GCST904761970.56
6575GALNT10/IGSF3 ratioGCST903149140.56
6576PODXL2/SCG3 ratioGCST903157000.56
6577CDSN/WFDC12 ratioGCST903139990.56
6578SEMA4D/TREML2 ratioGCST903158230.56
6579Patient classification on admission (recoded) - Inpatient | Summary AdministrationUKBB000006370.56
6580Concentration of small VLDL particles (UKB data field 23509)GCST902696060.55
6581ENPP2 levelsGCST904691150.55
6582EGFLAM levelsGCST904690840.55
6583ENPP5 levelsGCST904691160.55
6584DTI TBSS L3 FornixGCST903845290.55
6585TF levelsGCST904708410.55
6586Mental and behavioural disorders due to use of other stimulants, including caffeineFING000008110.55
6587CLPP/DECR1 ratioGCST903141370.55
6588ARHGAP45 levelsGCST904683550.55
6589Heart failureGCST903997120.55
6590eGFR in diabetes mellitus (full adjustment)GCST906247860.55
6591Diacylglycerol_34:1_[M+H-H2O]1+ levelsGCST900601790.55
6592Age-related macular degeneration (whether dry or wet)FING000000470.55
6593Free Cholesterol to Total Lipids in Medium VLDL percentageGCST904989880.55
6594ADAMTSL5 levelsGCST904682300.55
6595KLK8/WFDC12 ratioGCST903152590.55
6596Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney diseaseGCST902647960.55
6597IDP dMRI TBSS L3 Genu of corpus callosumGCST900041730.54
6598PROK1 levelsGCST904703360.54
6599Free cholesterol levels in medium VLDLGCST900929200.54
6600Peptic ulcer (excl. esophageal) | digestiveUKBB000006390.54
6601Neutrophill count (UKB data field 30140)GCST904680920.54
6602Spirits likingGCST900948480.54
6603INSR levelsGCST904696230.54
6604Operative procedures - No procedure performed | Summary OperationsUKBB000005840.54
6605LGALS3 levelsGCST904697610.54
6606Diastolic blood pressureGCST900259810.54
6607Total lipid levels in medium VLDLGCST900929220.54
6608Phospholipids in VLDLGCST905002660.54
6609PRUNE2 levelsGCST904703490.54
6610FAM20A levelsGCST904691850.54
6611Cholesterol to total lipids in large HDL percentage (UKB data field 23635)GCST902697320.54
6612Blood urea nitrogen (BUN, mean, inv-norm transformed)GCST904751650.54
6613Triglycerides in very large HDL (UKB data field 23557)GCST902696540.54
6614DTI autoptx L2 unc r tractGCST903851920.54
6615aparc-a2009s lh thickness S-intrapariet+P-transGCST900036580.54
6616Chronic nephritic syndromeFING000002950.53
6617Linoleic acid levelsGCST905023060.53
6618Never eat wheat vs no wheat restrictions (UKB data field 6144)GCST901329320.53
6619hemoglobin (mean, inv-norm transformed)GCST904753740.53
6620Phospholipids to total lipids ratio in small LDLGCST900929650.53
6621BACH1/SNX9 ratioGCST903134470.53
6622T1 FreeSurfer a2009s lh S postcentral volumeGCST903848820.53
6623TPK1 levelsGCST904709430.53
6624FKBP4 levelsGCST904692430.53
6625aparc-Desikan lh area parstriangularisGCST900030920.53
6626Crisps likingGCST900947470.53
6627RNF43 levelsGCST904224820.53
6628BCAM/EPO ratioGCST903134710.53
6629IL17RB levelsGCST904695630.53
6630X-04499--3,4-dihydroxybutyrate levelsGCST902434970.53
6631CD248 levelsGCST904686120.53
6632red blood cell count (RBC, minimum, inv-norm transformed)GCST904763530.53
6633Avocado likingGCST900946940.53
6634Diacylglycerol (14:0_18:2) levelsGCST900247050.53
6635CRTAP levelsGCST904688720.53
6636Pizza likingGCST900948100.53
6637CASP3/SERPINB9 ratioGCST903136420.53
6638Polyunsaturated fatty acids to total fatty acids percentageGCST905026480.53
6639Juvenile rheumatoid arthirtisFING000007060.52
6640SPRR3 levelsGCST904707370.52
6641IL6R levelsGCST904696020.52
6642CCL17 levelsGCST904685690.52
6643FLT4/ICAM2 ratioGCST903148600.52
6644Unspecified monoarthritis | musculoskeletalUKBB000008820.52
6645F-oily fish liking (derived food-liking factor)GCST900948040.52
6646SHBG levelsGCST905033150.52
6647CETN2 levelsGCST904687210.52
6648CD99L2 levelsGCST904686570.52
6649Excessive sweatingGCST0060900.52
6650NTF3 levelsGCST904700940.52
6651Docosahexaenoic acid levelsGCST905022540.52
6652S100A14 levelsGCST904705150.52
6653Diacylglycerol_34:0_[M+H-H2O]1+ levelsGCST900601810.52
6654CD84/DAG1 ratioGCST903139100.52
6655TDRKH levelsGCST904708270.52
6656Atrial fibrillation (MTAG)GCST904490540.52
6657T1 FreeSurfer DK rh cuneus areaGCST903856930.52
6658LDL cholesterol levelsGCST900928830.52
6659Number of sexual partners in opposite-sex sexual behaviorGCST900264810.52
6660Emotional abuseGCST905518450.52
6661GPKOW levelsGCST904693920.52
6662Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005650.51
66633-methyl-2-oxobutyrate levelsGCST901996770.51
6664Postmenopausal breast cancerGCST904281160.51
6665Prescriptions - ACE inhibitor|anti-hypertensiveUKBB000006570.51
6666aparc-DKTatlas rh thickness transversetemporalGCST900036010.51
6667ITGB1BP2/WASF1 ratioGCST903152240.51
6668Basal cell carcinomaGCST904681140.51
6669Haemorrhoids and perianal venous thrombosisFING000005990.51
6670Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636)GCST902697330.51
6671PRELP levelsGCST904703210.51
6672EIF4G1/HEXIM1 ratioGCST903146350.51
6673Concentration of small VLDL particlesGCST904998560.51
6674Polyunsaturated fatty acid levelsGCST905026180.51
6675F13B levelsGCST904691670.51
6676Triacylglycerol_52:2_[M+NH4]1+ levelsGCST900605110.50
6677ESR1 levelsGCST904691550.50
6678ASPSCR1 levelsGCST904683780.50
6679Prostate cancerGCST902747140.50
6680STMN3 levelsGCST902428940.50
6681CTRL levelsGCST904689070.50
6682Atrial fibrillationGCST0064140.50
6683NUDT5/RWDD1 ratioGCST903155800.50
6684Volume of left central nucleusGCST904748830.50
6685TTN levelsGCST904709840.50
6686MED18/TBL1X ratioGCST903154150.50
6687ICD10 C61: Malignant neoplasm of prostateGCST900438940.50
6688IL1R2 levelsGCST904695720.50
6689UMOD levelsGCST904710090.50
6690Alanine transaminase (ALT, maximum, inv-norm transformed)GCST904751090.50
6691NEXN levelsGCST904700300.50
6692DTI TBSS L1 Anterior corona radiata LGCST903844510.50
6693CLEC4G/MERTK ratioGCST903141210.50
6694Skin and soft tissue infectionsGCST900134110.50
6695SARG levelsGCST904705260.50
6696CCL17/CD69 ratioGCST903136840.50
6697Platelet crit | Blood countUKBB000006470.50
6698LEPR/NRCAM ratioGCST903153120.50
6699wg rh intensity-contrast cuneusGCST900038310.50
6700IDP dMRI ProbtrackX L1 slf rGCST900042680.50
6701CD22/FOLR2 ratioGCST903137580.50
6702CD38/RELT ratioGCST903138090.50
6703Phospholipids to Total Lipids in Very Small VLDL percentageGCST905008660.49
6704IL12RB1 levelsGCST904695500.49
6705GGCT levelsGCST904693340.49
6706Treatment/medication code - salbutamol | MedicationsUKBB000008570.49
6707Triglycerides to Total Lipids in Large LDL percentageGCST904981010.49
6708IDP T1 FAST ROIs L ventral striatumGCST900025590.49
6709Stearate 18:0 levelsGCST902434310.49
6710CD200/CLEC4G ratioGCST903137460.49
6711Total cholesterol minus HDL-C levels (UKB data field 23401)GCST902694980.49
6712Frequency of solarium/sunlamp use | Sun exposureUKBB000002650.49
6713IDP dMRI TBSS FA Genu of corpus callosumGCST900038790.49
6714aparc-a2009s rh area G-oc-temp-lat-fusiforGCST900033910.49
6715HippSubfield rh volume Whole-hippocampusGCST900027110.49
6716AmygNuclei rh volume Accessory-Basal-nucleusGCST900026600.49
6717Triglycerides to Total Lipids in IDL percentageGCST904976820.49
6718FAM3B/FGF19 ratioGCST903147760.49
6719Other and unspecified anaemiasFING000009250.49
6720LTBR levelsGCST904698160.49
6721DTI TBSS MD Cingulum cingulate gyrus LGCST903846070.49
6722Free Cholesterol to Total Lipids in Large VLDL percentageGCST904981990.49
6723Retinal arteriolar widthGCST902703980.49
6724Internal derangement of kneeFING000006840.48
6725Concentration of large LDL particlesGCST900928630.48
6726Cystatin C levels in bottom 99% of individuals by creatinine levelsGCST905667340.48
6727ADGRG2 levelsGCST904682410.48
6728GRHPR levelsGCST904694000.48
6729LGALS4/PCDH17 ratioGCST903153150.48
6730Trouble falling asleep when you first go to bedGCST904763850.48
6731Other bacterial intestinal infectionsFING000009690.48
6732Total testosterone levelsGCST902398200.48
6733Total lipids in small VLDL (UKB data field 23510)GCST902696070.48
6734Cholesteryl Esters in Medium LDLGCST904987390.48
6735OsteomyelitisFING000009110.48
6736Left-hemisphere dorsal attention network to thalamus white-matter structural connectivityGCST903027010.48
6737PAEP levelsGCST904701440.48
6738Tryptophan levelsGCST902434030.48
6739Other mental disorders due to brain damage and dysfunction and to physical diseaseFING000010720.48
6740Right hippocampal volume (tail)GCST902679730.48
6741Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levelsGCST905667370.48
6742Omega-3 fatty acids to total fatty acids percentageGCST904991630.48
6743Right-hemisphere visual network to right-hemisphere visual network white-matter structural connectivityGCST903027740.47
6744Citrate levels (UKB data field 23473)GCST902695700.47
6745Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025960.47
6746Volume of left cortico-amygdaloid transition areaGCST904748800.47
6747CCL18/TFPI ratioGCST903136910.47
6748ITGB1BP2/TIA1 ratioGCST903152220.47
6749Chronic sinusitis (PheCode 475)GCST904760200.47
6750Cardiac conduction disorders (PheCode 426)GCST904759520.47
6751Omega-6 fatty acid levelsGCST905021010.47
6752ADAMTS8 levelsGCST904682270.47
6753NECTIN2/SPON2 ratioGCST903155300.47
6754Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levelsGCST900602950.47
6755Immature reticulocyte fraction | Blood countUKBB000003550.47
6756LYN/SIRT2 ratioGCST903153490.47
6757DSG2 levelsGCST904278250.46
6758Linoleic acid to total fatty acids percentageGCST905023370.46
6759Concentration of small LDL particles (UKB data field 23544)GCST902696410.46
6760NRCAM/NTRK2 ratioGCST903155520.46
6761ALKBH3 levelsGCST906190950.46
6762Free cholesterol in small VLDL (UKB data field 23514)GCST902696110.46
6763Degree of unsaturationGCST905027360.46
6764PTPN6/YES1 ratioGCST903157500.46
6765ICD10 N97.0: Female infertility associated with anovulationGCST904542230.46
6766HS6ST1/MEGF9 ratioGCST903150810.46
6767Total lipid levels in lipoprotein particlesGCST905000850.46
6768Cholesterol levels in medium LDLGCST900929040.46
6769LILRA2 levelsGCST904697710.46
6770DTNB levelsGCST904690460.46
6771MAVS/MYO9B ratioGCST903153900.46
6772MAD1L1/POLR2F ratioGCST903153540.46
6773PRTN3 levelsGCST904703480.46
6774IRAK4 levelsGCST904696280.46
6775Phospholipids in large VLDLGCST904982470.46
6776AppendectomyFING000001040.46
6777SHBG levelsGCST904706220.46
6778MOCS2 levelsGCST904699280.46
6779Total cholesterol levelsGCST902786440.46
6780Concentration of HDL particles (UKB data field 23430)GCST902695270.46
6781Salmon likingGCST900948260.46
6782Linoleic acid to total fatty acids percentageGCST904983210.46
6783CCN5/IGFBP6 ratioGCST903137230.46
6784APOB levelsGCST902695360.46
6785Triglycerides to total lipids ratio in medium HDLGCST900929030.46
6786STAMBP levelsGCST904707560.45
6787Principal component-derived dietary pattern 26GCST901330310.45
6788F9/PROC ratioGCST903147480.45
6789T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76)GCST903206390.45
6790Cholesteryl esters in medium VLDL (UKB data field 23506)GCST902696030.45
6791VLDL cholesterol levels (UKB data field 23403)GCST902695000.45
6792Concentration of VLDL particlesGCST900930000.45
6793Left-hemisphere default mode network to amygdala white-matter structural connectivityGCST903027720.45
6794APOB levelsUKBB000000410.45
6795aparc-pial lh area parstriangularisGCST900031600.45
6796ITGA5/VCAM1 ratioGCST903152060.45
6797Prescriptions - bendroflumethiazide | thiazide diuretic,diureticUKBB000006670.45
6798T1 FreeSurfer DK rh cuneus volumeGCST903857610.44
6799CD69 levelsGCST904686430.44
6800Colon cancerGCST900118110.44
6801ADGRE2 levelsGCST904682370.44
6802GSTT2 levelsGCST900866520.44
6803Total lipids in small VLDLGCST904998400.44
6804Medication for pain relief, constipation, heartburn - Aspirin | MedicationUKBB000004540.44
6805Haemoglobin concentration | Blood countUKBB000002930.44
6806NUCB2/RSPO3 ratioGCST903155750.44
6807Treatment or medication use - rosuvastatin (UKB data field 20003_1141192410)GCST900425390.44
6808GSTA4 levelsGCST902412830.44
6809High light scatter reticulocyte count (UKB data field 30300)GCST904680760.44
6810aparc-Desikan rh thickness transversetemporalGCST900035110.44
6811ZP3 levelsGCST904711050.44
6812PPY levelsGCST904703090.44
6813Concentration of medium LDL particles (UKB data field 23537)GCST902696340.44
6814CD79B/FCRL2 ratioGCST903139000.44
6815BleedingFING000002190.44
6816wg rh intensity-contrast banksstsGCST900038280.44
6817Triglycerides to total lipids in large HDL percentage (UKB data field 23638)GCST902697350.44
6818neutrophil (absolute count, maximum, inv-norm transformed)GCST904755260.44
6819Cholesteryl esters in VLDL (UKB data field 23416)GCST902695130.44
6820Felt very upset when reminded of stressful experience in past month | Traumatic eventsUKBB000002430.44
6821BCAM/SEMA7A ratioGCST903134760.43
6822CD58/ROR1 ratioGCST903138540.43
6823HDL x low social support interaction (2df test)GCST905706690.43
6824Total lipids in medium HDL (UKB data field 23566)GCST902696630.43
6825Cancer code, self-reported - basal cell carcinoma | Medical conditionsUKBB000001170.43
6826CNPY4/STAT5B ratioGCST903141550.43
6827aparc-a2009s rh volume S-collat-transv-antGCST900030480.43
6828Total phospholipid levels in lipoprotein particlesGCST900929910.43
6829REG1A/REG4 ratioGCST903157620.43
6830PNLIPRP2 levelsGCST904702740.43
6831CCL15 levelsGCST904685670.43
6832NECTIN2/TNFRSF14 ratioGCST903155310.43
6833DTI TBSS L1 Anterior corona radiata RGCST903844500.43
6834C1QTNF1/COL18A1 ratioGCST903135510.43
6835CD200R1 levelsGCST904686050.43
6836EDAR/ITGB1BP2 ratioGCST903145800.43
683710-undecenoate (11:1n1) levelsGCST902435960.43
6838PTGR1 levelsGCST904703700.42
6839MINDY1 levelsGCST904699080.42
6840DNAJA2/FIS1 ratioGCST903145010.42
6841Hernia of abdominal wallFING000006170.42
6842PLXNB3 levelsGCST904702670.42
6843BAX/MAX ratioGCST903134660.42
6844DCBLD2/PLA2G15 ratioGCST903144280.42
6845TNFRSF21 levelsGCST904709120.42
6846Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivityGCST903027000.42
6847Concentration of IDL particles (UKB data field 23523)GCST902696200.42
6848SDHB levelsGCST904705610.42
6849N-acetyltaurine levelsGCST901999670.42
6850Cardiovascular diseases (excluding rheumatic etc)FING000002550.42
6851DTI autoptx MD ifo l tractGCST903852320.42
6852MSMB levelsGCST904699490.42
6853Cholesteryl Esters in Small HDLGCST904993820.42
6854F-healthy breakfast food liking (derived food-liking factor)GCST900947800.42
6855Family relationship satisfaction | Mental healthUKBB000002380.42
6856PAEP/RSPO1 ratioGCST903155930.42
6857ESM1 levelsGCST904691530.42
6858DBI levelsGCST904689490.42
6859T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 74)GCST903206370.42
6860Butyrylcarnitine levelsGCST902435890.42
6861Septal defectsFING000012930.42
6862DCTPP1 levelsGCST904689610.42
6863CRADD/EREG ratioGCST903142360.42
6864T1 FreeSurfer DK rh superiorparietal thicknessGCST903857510.41
6865Cholelithiasis | digestiveUKBB000001310.41
6866CERT levelsGCST904687170.41
6867Immature fraction of reticulocytesGCST900023870.41
6868REG1A/TFF3 ratioGCST903157640.41
6869DNA methylation-estimated granulocyte proportionsGCST900142870.41
6870STXBP1 levelsGCST904707770.41
6871aparc-a2009s rh area G-oc-temp-med-LingualGCST900033920.41
6872HSPB1 levelsGCST901793170.41
6873DSG3 levelsGCST904690430.41
6874HPCAL1 levelsGCST904694710.41
6875CLEC1A levelsGCST904687670.41
6876PON2 levelsGCST904702860.41
6877LBR/LGALS8 ratioGCST903152940.41
6878Total fatty acid levelsGCST900929870.41
6879FCRL1/TNFRSF13C ratioGCST903147960.41
6880Myocardial fractal dimension (slice 2)GCST900002880.41
6881EFNA1 levelsGCST904690800.41
6882Omega-3 fatty acid levelsGCST905024370.41
6883CCL13/CCL8 ratioGCST903136760.41
6884S100P levelsGCST904705200.41
6885Unspecified/other endometriosisFING000014040.41
6886CD79B/ICAM3 ratioGCST903139010.41
6887SCN4B levelsGCST904705510.41
6888High light scatter reticulocyte percentage (UKB data field 30290)GCST904680770.41
6889GP6/SEMA4D ratioGCST903149710.41
6890Breast cancerGCST0072360.40
6891Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levelsGCST900605570.40
6892AMBP/EFEMP1 ratioGCST903132530.40
6893MAVS/RNF41 ratioGCST903153950.40
6894Follicle stimulating hormone levelsGCST904834760.40
6895Cholesterol to total lipids ratio in medium HDLGCST900928930.40
6896Concentration of medium VLDL particlesGCST900929230.40
6897GP6/SCARF1 ratioGCST903149690.40
6898CST1 levelsGCST904688930.40
6899IDP dMRI ProbtrackX FA atr rGCST900039280.40
6900MAP4K5 levelsGCST904698550.40
6901CD74/LILRB4 ratioGCST903138940.40
6902Aspartate aminotransferase (AST, mean, inv-norm transformed)GCST904751210.40
6903triglyceride (maximum, inv-norm transformed)GCST904764310.40
6904Urine glucuronide of C10H18O2 (12)* levels in chronic kidney diseaseGCST902651890.40
6905Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T220ECGU0002200.40
6906Other diseases of upper respiratory tractFING000010120.40
6907Succinylcarnitine levelsGCST902438740.40
6908Concentration of large LDL particles (UKB data field 23530)GCST902696270.40
6909aseg global volume VentricleChoroidGCST900025980.40
6910aparc-DKTatlas lh area parstriangularisGCST900032520.39
6911Free cholesterol levels in VLDLGCST900929980.39
6912Sebaceous cyst (PheCode 706.2)GCST904762130.39
6913Worry too long after embarrassment | Mental healthUKBB000009220.39
6914Skin brightnessGCST905027770.39
6915Phospholipid levels in medium VLDLGCST900929240.39
6916Phospholipids to total lipids ratio in IDLGCST900928400.39
6917CETN2/PRTFDC1 ratioGCST903140300.39
6918IDP dMRI TBSS MO FornixGCST900039570.39
6919Moderate to vigorous physical activity durationGCST900614220.39
6920MOG/SEZ6L ratioGCST903154770.39
6921Allergic rhinitisGCST900860420.39
6922Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST905003730.39
6923HS6ST1 levelsGCST904694790.39
6924ITPA levelsGCST904696540.39
6925Free Cholesterol in HDLGCST904973790.39
6926GHRL levelsGCST904693410.39
6927Phospholipids in medium VLDL (UKB data field 23504)GCST902696010.39
6928Free Cholesterol in VLDLGCST905002210.39
6929Obesity due to excess caloriesFING000008960.39
6930FURIN levelsGCST904692770.39
6931LDLR/PCSK9 ratioGCST903153110.39
6932FLT1 levelsGCST904692490.39
6933Monoclonal gammopathy of undetermined significanceGCST906247450.38
6934Liver fatGCST900290730.38
6935IDP dMRI TBSS L2 Genu of corpus callosumGCST900041250.38
6936red cell diameter width (RDW, mean, inv-norm transformed)GCST904763610.38
6937SPRY2 levelsGCST904707380.38
6938SH3GLB2 levelsGCST904706210.38
6939MRC1 levelsGCST904699390.38
6940Neutrophil countGCST900023510.38
6941monocyte (absolute count, maximum, inv-norm transformed)GCST904754990.38
6942Total lipids in medium VLDLGCST904990040.38
6943ORM1 levelsGCST904701290.38
6944Carotid artery plaque burdenGCST905030760.38
6945Other disorders of breastFING000010180.38
6946Cholesteryl ester levels in large VLDLGCST900928700.38
6947IL12A_IL12B/LAG3 ratioGCST903151470.38
6948CLEC1B/MPIG6B ratioGCST903140980.38
6949CLEC3B levelsGCST904687700.38
6950IL18BP levelsGCST904695640.38
6951Severe autoimmune type 2 diabetesGCST900264120.38
6952Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary AdministrationUKBB000008370.38
6953T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125)GCST903209440.38
6954Free cholesterol levels in medium HDLGCST901326790.38
6955DTI TBSS MD Posterior corona radiata LGCST903845990.38
6956Total lipids in large LDL (UKB data field 23531)GCST902696280.38
6957SPP1 levelsGCST904707330.38
6958NT5E levelsGCST904700930.37
6959Cholesteryl esters in small LDL (UKB data field 23548)GCST902696450.37
6960PPME1/PSMD9 ratioGCST903157050.37
6961CA13 levelsGCST904685080.37
6962ENO2/FXYD5 ratioGCST903146590.37
6963Social trust (aggregated)GCST903193150.37
6964ADGRE5/GAS6 ratioGCST903131790.37
6965F11R/PLXNA4 ratioGCST903147240.37
6966Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T472ECGA0004720.37
6967creatinine (maximum, inv-norm transformed)GCST904752260.37
6968Bone density T-scoreGCST902786200.37
6969Cholesterol levels in small LDLGCST900929560.37
6970PRDX5 levelsGCST904703180.37
6971Ever suffered mental distress preventing usual activities | Mental distressUKBB000002230.37
6972CEP43/USP8 ratioGCST903140220.37
6973Descending aorta strainGCST902673890.37
6974T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97)GCST903209160.37
6975Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)GCST902697300.37
6976Blood urea nitrogen (BUN, minimum, inv-norm transformed)GCST904751680.37
6977AHSA1 levelsGCST904682620.37
6978F-sharp flavour liking (derived food-liking factor)GCST900948370.37
6979MASP1 levelsGCST904698630.37
6980ACYP2 levelsGCST902401870.37
6981CDH3 levelsGCST904686740.36
6982EDAR/TXNDC5 ratioGCST903145930.36
6983CLEC1A/CLEC7A ratioGCST903140830.36
6984Cholesterol esters in very large HDLGCST905003440.36
6985Cholelithiasis | Disorders of gallbladder, biliary tract and pancreasUKBB000001320.36
6986Degree of unsaturationGCST905001620.36
6987Phospholipids in small VLDL (UKB data field 23511)GCST902696080.36
6988CA2/PSMG3 ratioGCST903135810.36
6989Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST904981620.36
6990AXIN1/GOPC ratioGCST903134070.36
6991Frontotemporal dementiaFING000005600.36
6992Omega-6 fatty acids to omega-3 fatty acids ratioGCST904991940.36
6993IDP dMRI TBSS FA Uncinate fasciculus RGCST900039210.36
6994Platelet crit (UKB data field 30090)GCST904680960.36
6995Platelet count during third trimester of pregnancyGCST903022260.36
6996FGF19 levelsGCST904692200.36
6997Cholesteryl ester levels in VLDLGCST900929970.36
6998GLRX5 levelsGCST904693610.36
6999ERBIN levelsGCST904691420.36
7000LAMB1 levelsGCST904697320.36